---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-038897"
form_type: "8-K"
ticker: "BIAF"
cik: "0001712762"
company_name: "bioAffinity Technologies, Inc."
filed_at: "2026-08-18T12:30:29+00:00"
generated_at: "2026-08-18T12:35:12.005393+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# bioAffinity signs distribution agreement with AvMEDICAL for CyPath Lung in federal healthcare

## Summary
- Distribution agreement with AvMEDICAL (SDVOSB) to market CyPath Lung to federal agencies, including VA medical centers.
- AvMEDICAL's sales force and IDIQ contract access expected to expand government procurement of CyPath Lung.
- CyPath Lung clinical data: 92% sensitivity, 87% specificity, 88% accuracy, 99% NPV in high-risk patients with nodules <20mm.
- VA context: ~8,000 veterans diagnosed with lung cancer annually; ~5,000 die; early detection goal.
- Co-branded marketing and AvMEDICAL promotion to federal customers; no financial terms disclosed.

## SEC filing metadata
- accession: 0001493152-26-038897
- form_type: 8-K
- ticker: BIAF
- cik: 0001712762
- company_name: bioAffinity Technologies, Inc.
- filed_at: 2026-08-18T12:30:29+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1712762/000149315226038897/0001493152-26-038897-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1712762/000149315226038897/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-038897
- JSON: https://secwatch.observer/filing/0001493152-26-038897.json
- Plain text: https://secwatch.observer/filing/0001493152-26-038897.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.